Covalent assistance to supramolecular synthesis: modifying the drug functionality of the antituberculosis API isoniazidin situ during co-crystallization with GRAS and API compounds
Publication type: Journal Article
Publication date: 2012-01-01
scimago Q2
wos Q2
SJR: 0.520
CiteScore: 5.2
Impact factor: 2.6
ISSN: 14668033
General Chemistry
Condensed Matter Physics
General Materials Science
Abstract
The anti-tuberculosis molecule isonicotinic acid hydrazide (isoniazid) is a promising molecule in the supramolecular synthesis of multi-component molecular complexes and also allows for its biological activity to be improved and modified by a simple covalent reaction. The low temperature crystal structures of both isoniazid (1) and the related N′-(propan-2-ylidene)isonicotinohydrazide molecule (2), the latter known to be a more effective agent against Mycobacterium tuberculosis, are reported. In addition, these two molecules were then co-crystallized with the same three Generally Regarded As Safe (GRAS) molecules, succinic acid, 4-hydroxybenzoic acid and 2-hydroxybenzoic acid, to produce the following pharmaceutical co-crystals: (isonicotinic acid hydrazide)2·(succinic acid) 3, (N′-(propan-2-ylidene)isonicotinohydrazide)2·(succinic acid) 4, (isonicotinic acid hydrazide)·(4-hydroxybenzoic acid) 6, (N′-(propan-2-ylidene)isonicotinohydrazide)·(4-hydroxybenzoic acid) 7, (isonicotinic acid hydrazide)·(2-hydroxybenzoic acid) 8, and (N′-(propan-2-ylidene)isonicotinohydrazide)·(2-hydroxybenzoic acid) 9. In addition, a co-crystal using 2-butanone as a modifier is also reported, (N′-(butan-2-ylidene)isonicotinohydrazide)2·(succinic acid) 5. Drug–drug co-crystals were also made with the anti-HIV compound 2-chloro-4-nitrobenzoic acid: (isonicotinic acid hydrazide)·(2-chloro-4-nitrobenzoic acid) 10, and (N′-(propan-2-ylidene)isonicotinohydrazide)·(2-chloro-4-nitrobenzoic acid) 11. All the co-crystals use the carboxylic acid⋯pyridine hydrogen bond to connect the GRAS or drug molecule to the pyridine ring. In general, the co-crystals with the modified isoniazid feature the C(4) homosynthon, and those with the original isoniazid a variety of homo- and heterosynthons. By comparing the melting points of the co-crystals that use isoniazid and those that use the modified isoniazid, a reduction in melting point is observed.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
CrystEngComm
11 publications, 16.67%
|
|
|
Crystal Growth and Design
9 publications, 13.64%
|
|
|
Journal of Molecular Structure
7 publications, 10.61%
|
|
|
Acta crystallographica. Section C, Structural chemistry
3 publications, 4.55%
|
|
|
RSC Advances
3 publications, 4.55%
|
|
|
Crystals
2 publications, 3.03%
|
|
|
Journal of Physical Chemistry B
1 publication, 1.52%
|
|
|
Acta Crystallographica Section E Structure Reports Online
1 publication, 1.52%
|
|
|
Chemistry Central Journal
1 publication, 1.52%
|
|
|
Chemical Research in Chinese Universities
1 publication, 1.52%
|
|
|
BMC pharmacology & toxicology
1 publication, 1.52%
|
|
|
Journal of Thermal Analysis and Calorimetry
1 publication, 1.52%
|
|
|
International Journal of Pharmaceutics
1 publication, 1.52%
|
|
|
Chemical Physics
1 publication, 1.52%
|
|
|
Journal of Chemical Thermodynamics
1 publication, 1.52%
|
|
|
Chemical Engineering Science
1 publication, 1.52%
|
|
|
Optical Materials
1 publication, 1.52%
|
|
|
Drug Discovery Today
1 publication, 1.52%
|
|
|
Computational and Theoretical Chemistry
1 publication, 1.52%
|
|
|
Molecules
1 publication, 1.52%
|
|
|
Ultrasonics Sonochemistry
1 publication, 1.52%
|
|
|
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
1 publication, 1.52%
|
|
|
Molecular Pharmaceutics
1 publication, 1.52%
|
|
|
ACS Omega
1 publication, 1.52%
|
|
|
Journal of Chemical & Engineering Data
1 publication, 1.52%
|
|
|
Chemical Communications
1 publication, 1.52%
|
|
|
Journal of Structural Chemistry
1 publication, 1.52%
|
|
|
Medical Advancements in Aging and Regenerative Technologies
1 publication, 1.52%
|
|
|
Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials
1 publication, 1.52%
|
|
|
Zeitschrift fur Physikalische Chemie
1 publication, 1.52%
|
|
|
2
4
6
8
10
12
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
21 publications, 31.82%
|
|
|
Royal Society of Chemistry (RSC)
16 publications, 24.24%
|
|
|
American Chemical Society (ACS)
13 publications, 19.7%
|
|
|
International Union of Crystallography (IUCr)
5 publications, 7.58%
|
|
|
Springer Nature
4 publications, 6.06%
|
|
|
MDPI
3 publications, 4.55%
|
|
|
Pleiades Publishing
1 publication, 1.52%
|
|
|
IGI Global
1 publication, 1.52%
|
|
|
Walter de Gruyter
1 publication, 1.52%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.52%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
66
Total citations:
66
Citations from 2025:
2
(3.03%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Lemmerer A. Covalent assistance to supramolecular synthesis: modifying the drug functionality of the antituberculosis API isoniazidin situ during co-crystallization with GRAS and API compounds // CrystEngComm. 2012. Vol. 14. No. 7. pp. 2465-2478.
GOST all authors (up to 50)
Copy
Lemmerer A. Covalent assistance to supramolecular synthesis: modifying the drug functionality of the antituberculosis API isoniazidin situ during co-crystallization with GRAS and API compounds // CrystEngComm. 2012. Vol. 14. No. 7. pp. 2465-2478.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1039/C1CE06310C
UR - https://doi.org/10.1039/C1CE06310C
TI - Covalent assistance to supramolecular synthesis: modifying the drug functionality of the antituberculosis API isoniazidin situ during co-crystallization with GRAS and API compounds
T2 - CrystEngComm
AU - Lemmerer, Andreas
PY - 2012
DA - 2012/01/01
PB - Royal Society of Chemistry (RSC)
SP - 2465-2478
IS - 7
VL - 14
SN - 1466-8033
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2012_Lemmerer,
author = {Andreas Lemmerer},
title = {Covalent assistance to supramolecular synthesis: modifying the drug functionality of the antituberculosis API isoniazidin situ during co-crystallization with GRAS and API compounds},
journal = {CrystEngComm},
year = {2012},
volume = {14},
publisher = {Royal Society of Chemistry (RSC)},
month = {jan},
url = {https://doi.org/10.1039/C1CE06310C},
number = {7},
pages = {2465--2478},
doi = {10.1039/C1CE06310C}
}
Cite this
MLA
Copy
Lemmerer, Andreas. “Covalent assistance to supramolecular synthesis: modifying the drug functionality of the antituberculosis API isoniazidin situ during co-crystallization with GRAS and API compounds.” CrystEngComm, vol. 14, no. 7, Jan. 2012, pp. 2465-2478. https://doi.org/10.1039/C1CE06310C.